查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1940997

子痫前症检测市场：市场洞察、竞争格局及预测（2033 年）

Preeclampsia Laboratory Testing Market Insights, Competitive Landscape, and Market Forecast - 2033
出版日期: | 出版商: Fairfield Market Research | 英文 191 Pages | 商品交期: 2-5个工作天内

价格
简介目录

全球子痫前症检测市场预计将显着成长，2026 年达到 14 亿美元，2033 年达到 23 亿美元，预测期内复合年增长率 (CAGR) 为 8.0%。人们对孕产妇健康併发症的认识不断提高，加上诊断检测技术的进步，预计将推动全球医疗机构采用子痫前症检测。

市场洞察

子痫前症（简称子痫前症）是一种妊娠期高血压疾病，是导致孕产妇和新生儿发病率和死亡率的重要因素。透过可靠的检测方法进行早期发现对于控制病情和预防严重併发症（如子痫、器官损伤和早产）至关重要。基于尿液和血液检测的诊断方法正变得越来越重要，有助于临床医生评估疾病的严重程度并在适当的时候进行干预。

代谢组学生物标记和免疫测定等诊断技术的创新，进一步提高了子痫前症检测的准确性和效率。这些技术进步，加上产前筛检计画的不断增加，使医疗保健提供者能够为高风险孕妇提供个人化照护。

市场驱动因素

子痫前症检测市场的成长主要受以下关键因素驱动：

  • 1. 孕产妇健康意识的提高：世界各国政府和非政府组织都在推广常规产前筛检，包括子痫前症检测，以降低孕产妇死亡率。这推动了对可靠诊断检测的需求。
  • 2. 技术进步：高灵敏度血液和尿液检测方法的开发，结合了用于早期检测的生物标记物，使先兆子痫的诊断更加便捷和准确。
  • 3.妊娠高血压疾病盛行率上升：流行病学研究表明，子痫前症的发生率不断上升，尤其是在城市地区，这推动了对检测的需求。
  • 4. 政府支持性政策和资金投入：对孕产妇保健基础设施和产前保健计画的投资，鼓励医疗保健提供者采用先进的诊断工具进行疾病早期检测。
  • 5. 与个人化医疗结合：实验室正在利用新的生物标记来制定个人化的监测和介入策略，从而优化孕妇的整体护理路径。

商机

该市场为诊断设备製造商和医疗保健提供者提供了广泛的商机。主要业务前景包括：

  • 新兴经济体的扩张：亚太和拉丁美洲等地区产前保健计画的扩展，为检测设备製造商提供了重要的成长途径。
  • 产品组合多元化：企业可以透过开发基于尿液和血液的诊断解决方案来抓住市场机遇，以应对不同严重程度的妊娠高血压。
  • 策略联盟与合作：诊断设备製造商与医院和妇产科诊所之间的合作可以扩大市场渗透率，并促进创新检测方法的应用。
  • 研发投入：持续研究预测性生物标记和即时诊断解决方案可以提供市场竞争优势。

区域分析

北美市场领先，这得益于其完善的医疗保健基础设施、对孕产妇健康问题的广泛关注以及大规模的研究计划。该地区还受益于技术先进的实验室诊断的高普及率。

欧洲预计将成为第二大市场，这得益于其完善的产前保健计划和政府主导的促进疾病早期发现的举措。

由于医疗保健支出增加、产前护理普及以及孕妇对妊娠併发症的认识提高，亚太市场预计将成长最快。

由于医疗保健基础设施逐步改善以及公共和私营部门利益相关者对孕产妇健康的日益重视，拉丁美洲和中东及非洲市场预计将实现温和增长。

主要参与者

全球子痫前症检测市场竞争激烈，多家大型公司在产品开发和市场扩张方面处于领先地位。 主要公司包括：

  • DiabetOmics
  • DRG Instruments GmbH
  • Hoffmann-La Roche Ltd.
  • GestVision, Inc.
  • Lifeassay Diagnostics (Pty) Ltd.
  • Metabolomic Diagnostics
  • Perkin Elmer, Inc.
  • Progenity, Inc.
  • Quidel Corporation
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.

这些公司正透过创新的诊断平台、策略合作伙伴关係以及向新兴地区的扩张来巩固其市场地位。

市场区隔

子痫前症检测市场可依据侦测类型、子痫前症类型、最终使用者和地理区域进行细分：

依检测类型

  • 尿液检测
  • 血液检测

依子痫前症类型

  • 轻度
  • 重度

依最终使用者

  • 医院和诊所
  • 诊断中心
  • 其他

依地区

  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

目录目录

第一章：摘要整理

第二章：市场概览

  • 市场定义与细分
  • 市场动态
    • 驱动因素
    • 限制因素
    • 市场机遇
  • 价值链分析
  • 新冠疫情影响分析
  • 波特五力分析
  • 俄乌衝突的影响
  • PESTLE分析
  • 监理分析
  • 价格趋势分析
    • 当前价格及未来预测（2025-2033年）
    • 价格影响因素

第三章：全球子痫前症检测市场预测 2020-2033

  • 全球子痫前症市场预测，依检测类型划分，收入（十亿美元），2020-2033
    • 尿液检测
    • 血液检测
  • 全球子痫前症检测市场预测，以子痫前症类型划分，收入（十亿美元），2020-2033
    • 轻度
    • 重度
  • 全球子痫前症检测市场预测，以最终用户划分，价值（十亿美元），2020-2033
    • 医院和诊所
    • 诊断中心
  • 全球子痫前症市场预测，依地区划分，价值（十亿美元），2020-2033
    • 北美美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第四章：北美子痫前症检测市场展望（2020-2033）

第五章：欧洲子痫前症检测市场展望（2020-2033）

第六章：亚太地区子痫前症检测市场展望（2020-2033）

第七章：拉丁美洲子痫前症检测市场展望（2020-2033）

第八章：中东和非洲子痫前症检测市场展望（2020-2033）

第九章：竞争格局概览

  • 公司与细分市场热力图
  • 公司市占率分析（2025 年）
  • 竞争格局概览
  • 公司简介
    • DiabetOmics
    • DRG Instruments GmbH
    • Hoffmann-La Roche Ltd.
    • GestVision, Inc.
    • Lifeassay Diagnostics (Pty) Ltd.
    • Metabolomic Diagnostics
    • Perkin Elmer, Inc.
    • Progenity, Inc.
    • Quidel Corporation
    • Siemens Healthineers

第十章附录

简介目录

The global Preeclampsia Laboratory Testing Market is poised for substantial growth, with a projected valuation of USD 1.4 billion in 2026, expected to reach USD 2.3 billion by 2033, growing at a compound annual growth rate (CAGR) of 8.0% during the forecast period. Increasing awareness of maternal health complications, coupled with advancements in laboratory diagnostics, is set to drive the adoption of preeclampsia testing across healthcare settings worldwide.

Market Insights

Preeclampsia, a hypertensive disorder occurring during pregnancy, remains a significant contributor to maternal and neonatal morbidity and mortality. Early detection through reliable laboratory testing plays a crucial role in managing the condition and preventing severe complications such as eclampsia, organ damage, and preterm birth. The market is witnessing increasing emphasis on both urine and blood-based diagnostic assays, which help clinicians assess the severity of the disease and guide timely interventions.

Innovations in diagnostic technologies, including metabolomics-based biomarkers and immunoassays, are further enhancing the accuracy and efficiency of preeclampsia detection. Coupled with rising prenatal screening initiatives, these technological advancements are enabling healthcare providers to offer personalized care for at-risk pregnant women.

Market Drivers

The growth of the Preeclampsia Laboratory Testing Market is fueled by several key factors:

  • 1. Rising Maternal Health Awareness: Governments and NGOs worldwide are advocating for routine prenatal screenings, including preeclampsia testing, to reduce maternal mortality rates. This has led to increased demand for reliable laboratory diagnostics.
  • 2. Technological Advancements: The development of highly sensitive blood and urine tests, incorporating biomarkers for early detection, has made preeclampsia diagnostics more accessible and precise.
  • 3. Growing Prevalence of Hypertensive Disorders in Pregnancy: Epidemiological studies indicate an increasing incidence of preeclampsia, particularly in urban populations, which drives demand for laboratory testing.
  • 4. Supportive Government Policies and Funding: Investment in maternal healthcare infrastructure and prenatal care programs is encouraging healthcare providers to adopt advanced diagnostic tools for early disease detection.
  • 5. Integration with Personalized Medicine: Laboratories are leveraging novel biomarkers to customize monitoring and intervention strategies, enhancing the overall care pathway for pregnant women.

Business Opportunities

The market offers extensive opportunities for diagnostic manufacturers and healthcare providers. Key business prospects include:

  • Expansion in Emerging Economies: Growing prenatal care programs in regions like Asia Pacific and Latin America present a significant growth avenue for laboratory test manufacturers.
  • Product Portfolio Diversification: Companies can capitalize on developing both urine- and blood-based diagnostic solutions tailored to different preeclampsia severities.
  • Strategic Collaborations and Partnerships: Partnerships between diagnostics companies and hospitals or prenatal clinics can enhance market reach and streamline adoption of innovative tests.
  • Investment in R&D: Continuous research into predictive biomarkers and point-of-care diagnostic solutions can offer a competitive advantage in the market.

Regional Analysis

North America dominates the market owing to well-established healthcare infrastructure, widespread awareness of maternal health issues, and extensive research initiatives. The region also benefits from high adoption of technologically advanced laboratory diagnostics.

Europe follows closely, supported by robust prenatal care programs and government-led initiatives promoting early disease detection.

The Asia Pacific market is expected to witness the fastest growth due to increasing healthcare expenditure, expanding prenatal care coverage, and rising awareness of maternal complications among pregnant women.

Latin America and the Middle East & Africa are anticipated to see moderate growth, driven by gradual improvements in healthcare infrastructure and increasing focus on maternal health by public and private stakeholders.

Key Players

The global preeclampsia laboratory testing market is highly competitive, with several prominent companies leading product development and market expansion initiatives. Key players include:

  • DiabetOmics
  • DRG Instruments GmbH
  • Hoffmann-La Roche Ltd.
  • GestVision, Inc.
  • Lifeassay Diagnostics (Pty) Ltd.
  • Metabolomic Diagnostics
  • Perkin Elmer, Inc.
  • Progenity, Inc.
  • Quidel Corporation
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.

These companies are focusing on innovative diagnostic platforms, strategic collaborations, and expansion into emerging regions to strengthen their market presence.

Market Segmentation

The Preeclampsia Laboratory Testing Market can be segmented based on test type, preeclampsia type, end user, and geographic coverage:

By Test Type

  • Urine Tests
  • Blood Tests

By Preeclampsia Type

  • Mild Preeclampsia
  • Severe Preeclampsia

By End User

  • Hospitals and Clinics
  • Diagnostic Centres
  • Others

By Geographic Coverage

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Preeclampsia Laboratory Testing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Fiver Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Preeclampsia Laboratory Testing Market Outlook, 2020-2033

  • 3.1. Global Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
    • 3.1.1. Urine Tests
    • 3.1.2. Blood Tests
  • 3.2. Global Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, Value (US$ Bn), 2020-2033
    • 3.2.1. Mild Preeclampsia
    • 3.2.2. Severe Preeclampsia
  • 3.3. Global Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 3.3.1. Hospitals and Clinics
    • 3.3.2. Diagnostic Centres
  • 3.4. Global Preeclampsia Laboratory Testing Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. Middle East & Africa

4. North America Preeclampsia Laboratory Testing Market Outlook, 2020-2033

  • 4.1. North America Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
    • 4.1.1. Urine Tests
    • 4.1.2. Blood Tests
  • 4.2. North America Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, Value (US$ Bn), 2020-2033
    • 4.2.1. Mild Preeclampsia
    • 4.2.2. Severe Preeclampsia
  • 4.3. North America Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 4.3.1. Hospitals and Clinics
    • 4.3.2. Diagnostic Centres
  • 4.4. North America Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.4.1. U.S. Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 4.4.2. U.S. Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 4.4.3. U.S. Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 4.4.4. Canada Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 4.4.5. Canada Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 4.4.6. Canada Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
  • 4.5. BPS Analysis/Market Attractiveness Analysis

5. Europe Preeclampsia Laboratory Testing Market Outlook, 2020-2033

  • 5.1. Europe Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
    • 5.1.1. Urine Tests
    • 5.1.2. Blood Tests
  • 5.2. Europe Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, Value (US$ Bn), 2020-2033
    • 5.2.1. Mild Preeclampsia
    • 5.2.2. Severe Preeclampsia
  • 5.3. Europe Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 5.3.1. Hospitals and Clinics
    • 5.3.2. Diagnostic Centres
  • 5.4. Europe Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.4.1. Germany Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 5.4.2. Germany Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 5.4.3. Germany Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 5.4.4. Italy Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 5.4.5. Italy Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 5.4.6. Italy Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 5.4.7. France Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 5.4.8. France Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 5.4.9. France Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 5.4.10. U.K. Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 5.4.11. U.K. Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 5.4.12. U.K. Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 5.4.13. Spain Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 5.4.14. Spain Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 5.4.15. Spain Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 5.4.16. Russia Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 5.4.17. Russia Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 5.4.18. Russia Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 5.4.19. Rest of Europe Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 5.4.20. Rest of Europe Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 5.4.21. Rest of Europe Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
  • 5.5. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, 2020-2033

  • 6.1. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
    • 6.1.1. Urine Tests
    • 6.1.2. Blood Tests
  • 6.2. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, Value (US$ Bn), 2020-2033
    • 6.2.1. Mild Preeclampsia
    • 6.2.2. Severe Preeclampsia
  • 6.3. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 6.3.1. Hospitals and Clinics
    • 6.3.2. Diagnostic Centres
  • 6.4. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.4.1. China Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 6.4.2. China Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 6.4.3. China Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 6.4.4. Japan Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 6.4.5. Japan Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 6.4.6. Japan Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 6.4.7. South Korea Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 6.4.8. South Korea Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 6.4.9. South Korea Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 6.4.10. India Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 6.4.11. India Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 6.4.12. India Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 6.4.13. Southeast Asia Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 6.4.14. Southeast Asia Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 6.4.15. Southeast Asia Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 6.4.16. Rest of SAO Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 6.4.17. Rest of SAO Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 6.4.18. Rest of SAO Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
  • 6.5. BPS Analysis/Market Attractiveness Analysis

7. Latin America Preeclampsia Laboratory Testing Market Outlook, 2020-2033

  • 7.1. Latin America Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
    • 7.1.1. Urine Tests
    • 7.1.2. Blood Tests
  • 7.2. Latin America Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, Value (US$ Bn), 2020-2033
    • 7.2.1. Mild Preeclampsia
    • 7.2.2. Severe Preeclampsia
  • 7.3. Latin America Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 7.3.1. Hospitals and Clinics
    • 7.3.2. Diagnostic Centres
  • 7.4. Latin America Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.4.1. Brazil Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 7.4.2. Brazil Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 7.4.3. Brazil Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 7.4.4. Mexico Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 7.4.5. Mexico Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 7.4.6. Mexico Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 7.4.7. Argentina Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 7.4.8. Argentina Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 7.4.9. Argentina Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 7.4.10. Rest of LATAM Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 7.4.11. Rest of LATAM Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 7.4.12. Rest of LATAM Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
  • 7.5. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, 2020-2033

  • 8.1. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
    • 8.1.1. Urine Tests
    • 8.1.2. Blood Tests
  • 8.2. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, Value (US$ Bn), 2020-2033
    • 8.2.1. Mild Preeclampsia
    • 8.2.2. Severe Preeclampsia
  • 8.3. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 8.3.1. Hospitals and Clinics
    • 8.3.2. Diagnostic Centres
  • 8.4. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.4.1. GCC Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 8.4.2. GCC Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 8.4.3. GCC Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 8.4.4. South Africa Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 8.4.5. South Africa Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 8.4.6. South Africa Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 8.4.7. Egypt Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 8.4.8. Egypt Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 8.4.9. Egypt Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 8.4.10. Nigeria Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 8.4.11. Nigeria Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 8.4.12. Nigeria Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 8.4.13. Rest of Middle East Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 8.4.14. Rest of Middle East Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 8.4.15. Rest of Middle East Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
  • 8.5. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. DiabetOmics
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. DRG Instruments GmbH
    • 9.4.3. Hoffmann-La Roche Ltd.
    • 9.4.4. GestVision, Inc.
    • 9.4.5. Lifeassay Diagnostics (Pty) Ltd.
    • 9.4.6. Metabolomic Diagnostics
    • 9.4.7. Perkin Elmer, Inc.
    • 9.4.8. Progenity, Inc.
    • 9.4.9. Quidel Corporation
    • 9.4.10. Siemens Healthineers

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations